2 More Pharmaceutical Companies, Abbvie and Genentech, to Officially Launch on TrumpRx

TL;DR

Abbvie and Genentech are the 10th and 11th companies to join the TrumpRx discounted pharmaceutical site.
Abbvie will offer Humira at an 86% discount, reducing the price for uninsured individuals from over $6,900 to $950.
Genentech will sell Xofluza for around $50, down from $168.
The discounts on TrumpRx are available to patients who are uninsured or whose insurance does not cover the medication.
The Trump administration is working to codify these discount deals and potentially allow copay usage for government insurance patients.
Amgen will also expand its offerings on TrumpRx to include Enbrel and Otezla.
TrumpRx now features over 61 drugs at lower prices.

Continuer la lecture de l'article original